Zhongqi Dong

Physiologically based pharmacokinetic model of renally cleared antibacterial drugs in Chinese renal impairment patients

Dongyang Liu, Xueting Yao, Miao Zhang, 2020, Biopharmaceutics & drug disposition.

Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).

J. Polli, Shiew-Mei Huang, Wei Zhang, 2013, Toxicology and applied pharmacology.

A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide.

J. Polli, S. Ekins, Zhongqi Dong, 2015, International journal of pharmaceutics.

Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects

Dongyang Liu, O. Hatley, Xueting Yao, 2020, British journal of clinical pharmacology.

Development of a Virtual Chinese Pediatric Population Physiological Model Targeting Specific Metabolism and Kidney Elimination Pathways

Dongyang Liu, F. Salem, Xueting Yao, 2021, Frontiers in Pharmacology.

Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).

Sean Ekins, Zhongqi Dong, James E Polli, 2013, Molecular pharmaceutics.

Structure Activity Relationship for FDA Approved Drugs as Inhibitors of the Human Sodium Taurocholate Co-transporting Polypeptide (NTCP)

J. Polli, S. Ekins, Zhongqi Dong, 2012 .

Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1.

J. Polli, Qing Li, Yan Shu, 2013, Molecular pharmaceutics.

Application of Physiologically‐Based Pharmacokinetic Modeling to Predict Gastric pH‐Dependent Drug–Drug Interactions for Weak Base Drugs

Lei Zhang, P. Zhao, Fang Wu, 2020, CPT: pharmacometrics & systems pharmacology.

Nano-MgO composites containing plasmid DNA to silence SNCA gene displays neuroprotective effects in Parkinson's rats induced by 6-hydroxydopamine.

Z. Zeng, Yanqing Guan, Zhongqi Dong, 2022, European journal of pharmacology.

Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver.

J. Polli, Qing Li, Yan Shu, 2015, Journal of pharmaceutical sciences.

Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.

Sean Ekins, Zhongqi Dong, James E Polli, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.